Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy

Kidney International(2025)10.1016/j.kint.2025.04.018Source: DataRank Database

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy is a research paper published in Kidney International (2025). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 4.76)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Michael D. Evans ORCID,Maria J. Vargas-Brochero ORCID,Nicholas Marka ORCID,Fernando C. Fervenza ORCID,Sanjeev Sethi ORCID

Live enrichment

PubMed:40403931 PMC:PMC12225640 OpenAlex:https://openalex.org/W4410539937

National Center for Advancing Translational Sciences

Grant: UM1TR004405

NCATS NIH HHS

Grant: UL1 TR002494

NIH

FWCI

4.76

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12225640/

publisherhttps://api.elsevier.com/content/article/PII:S0085253825003965?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0085253825003965?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.kint.2025.04.018

Fields of Study

Amyloidosis: Diagnosis, Treatment, OutcomesMultiple Myeloma Research and TreatmentsRenal Diseases and Glomerulopathies

MeSH Terms

AgedBiopsyFemaleHumansKidneyMaleMiddle AgedParaproteinemiasPredictive Value of TestsProteinuriaRetrospective StudiesRisk FactorsRisk AssessmentRenal Insufficiency, Chronic

Keywords

Monoclonal gammopathyMonoclonal gammopathy of undetermined significanceMedicineKidneyBiopsyMultiple myelomaInternal medicineMonoclonalMonoclonal antibodyImmunologyAntibodyRenal biopsyKidney BiopsyMgusMgrsMonoclonal Gammopathy Of Renal Significance

Sustainable Development Goals

SDG 0: Zero hunger